713 related articles for article (PubMed ID: 22493463)
1. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
Liang PS; Wheat CL; Abhat A; Brenner AT; Fagerlin A; Hayward RA; Thomas JP; Vijan S; Inadomi JM
Am J Gastroenterol; 2016 Jan; 111(1):105-14. PubMed ID: 26526080
[TBL] [Abstract][Full Text] [Related]
3. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
[TBL] [Abstract][Full Text] [Related]
5. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients.
Wu BU; Longstreth GF; Ngor EW
Gastrointest Endosc; 2014 Nov; 80(5):852-61.e1-2. PubMed ID: 24814774
[TBL] [Abstract][Full Text] [Related]
6. Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes.
Feldstein AC; Perrin N; Liles EG; Smith DH; Rosales AG; Schneider JL; Lafata JE; Myers RE; Mosen DM; Glasgow RE
Med Decis Making; 2012; 32(1):198-208. PubMed ID: 21652776
[TBL] [Abstract][Full Text] [Related]
7. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening.
May FP; Almario CV; Ponce N; Spiegel BM
Am J Gastroenterol; 2015 Oct; 110(10):1388-94. PubMed ID: 25964227
[TBL] [Abstract][Full Text] [Related]
8. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
[TBL] [Abstract][Full Text] [Related]
9. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans.
Walsh JM; Kaplan CP; Nguyen B; Gildengorin G; McPhee SJ; Pérez-Stable EJ
J Gen Intern Med; 2004 Feb; 19(2):156-66. PubMed ID: 15009795
[TBL] [Abstract][Full Text] [Related]
10. Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites.
Wong ST; Gildengorin G; Nguyen T; Mock J
Cancer; 2005 Dec; 104(12 Suppl):2940-7. PubMed ID: 16276538
[TBL] [Abstract][Full Text] [Related]
11. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
Robertson DJ; Dominitz JA; Beed A; Boardman KD; Del Curto BJ; Guarino PD; Imperiale TF; LaCasse A; Larson MF; Gupta S; Lieberman D; Planeta B; Shaukat A; Sultan S; Menees SB; Saini SD; Schoenfeld P; Goebel S; von Rosenvinge EC; Baffy G; Halasz I; Pedrosa MC; Kahng LS; Cassim R; Greer KB; Kinnard MF; Bhatt DB; Dunbar KB; Harford WV; Mengshol JA; Olson JE; Patel SG; Antaki F; Fisher DA; Sullivan BA; Lenza C; Prajapati DN; Wong H; Beyth R; Lieb JG; Manlolo J; Ona FV; Cole RA; Khalaf N; Kahi CJ; Kohli DR; Rai T; Sharma P; Anastasiou J; Hagedorn C; Fernando RS; Jackson CS; Jamal MM; Lee RH; Merchant F; May FP; Pisegna JR; Omer E; Parajuli D; Said A; Nguyen TD; Tombazzi CR; Feldman PA; Jacob L; Koppelman RN; Lehenbauer KP; Desai DS; Madhoun MF; Tierney WM; Ho MQ; Hockman HJ; Lopez C; Carter Paulson E; Tobi M; Pinillos HL; Young M; Ho NC; Mascarenhas R; Promrat K; Mutha PR; Pandak WM; Shah T; Schubert M; Pancotto FS; Gawron AJ; Underwood AE; Ho SB; Magno-Pagatzaurtundua P; Toro DH; Beymer CH; Kaz AM; Elwing J; Gill JA; Goldsmith SF; Yao MD; Protiva P; Pohl H; Kyriakides T;
JAMA Netw Open; 2023 Jul; 6(7):e2321730. PubMed ID: 37432690
[TBL] [Abstract][Full Text] [Related]
12. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
13. Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults.
Horne HN; Phelan-Emrick DF; Pollack CE; Markakis D; Wenzel J; Ahmed S; Garza MA; Shapiro GR; Bone LR; Johnson LB; Ford JG
Cancer Causes Control; 2015 Feb; 26(2):239-246. PubMed ID: 25516073
[TBL] [Abstract][Full Text] [Related]
14. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
Trials; 2015 Jul; 16():296. PubMed ID: 26156248
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effect of a decision aid plus patient navigation with usual care on colorectal cancer screening completion in vulnerable populations: study protocol for a randomized controlled trial.
Brenner AT; Getrich CM; Pignone M; Rhyne RL; Hoffman RM; McWilliams A; de Hernandez BU; Weaver MA; Tapp H; Harbi K; Reuland D
Trials; 2014 Jul; 15():275. PubMed ID: 25004983
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening: what do women from diverse ethnic groups want?
Walsh JM; Kim SE; Sawaya G; Kaplan CP; Wong ST; Gregorich SE; Pérez-Stable EJ
J Gen Intern Med; 2013 Feb; 28(2):239-46. PubMed ID: 22968796
[TBL] [Abstract][Full Text] [Related]
17. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
[TBL] [Abstract][Full Text] [Related]
18. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.
Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2017 Nov; 123(22):4472-4480. PubMed ID: 28753230
[TBL] [Abstract][Full Text] [Related]
19. Sociocultural and health correlates related to colorectal cancer screening adherence among urban African Americans.
Brittain K; Murphy VP
Cancer Nurs; 2015; 38(2):118-24. PubMed ID: 24836955
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
